Get access to our best features
Get access to our best features
Published 1 year ago

Eli Lilly CEO weighs in on Q4 revenue miss

Summary by CNBC
Eli Lilly CEO David Ricks joins 'Squawk Box' to discuss the company's change in guidance, the outlook for the company's Diabetes drug, and Eli Lilly's manufacturing capacity of the new drug, Mounjaro.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)